Oncolytics Biotech (ONCY) EBT (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly EBT came in at -$10.6 million in Q3 2025, down 52.38% year-on-year from -$22.4 million in Q3 2024, and down 120.61% on a QoQ basis from -$4.8 million in Q2 2025.
Oncolytics Biotech (ONCY) EBT (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 17 years of EBT data on file, last reported at -$10.6 million in Q3 2025.
- On a quarterly basis, EBT fell 52.38% year-over-year to -$10.6 million in Q3 2025; TTM through Sep 2025 was -$28.2 million, a 265.11% decrease from a year earlier, with the FY2025 full-year figure at -$28.7 million, down 26.35% from the prior year.
- EBT for Q3 2025 stood at -$10.6 million, down from -$4.8 million in the prior quarter.
- Over the last five years, EBT for ONCY reached as high as $7.3 million in Q3 2023 and fell as low as -$35.6 million in Q4 2021.
- Historically, EBT has averaged -$6.2 million across 5 years, with a median of -$5.1 million in 2021.
- On a YoY basis, EBT climbed as much as 330.96% in 2023 and fell as far as 243.76% in 2023.
- Year by year, EBT stood at -$35.6 million in 2021, then grew by 15.76% to -$30.0 million in 2022, then soared by 90.58% to -$2.8 million in 2023, then slumped by 102.62% to -$5.7 million in 2024, then sank by 86.05% to -$10.6 million in 2025.
- Per Business Quant data, the three most recent EBT figures were -$10.6 million in Q3 2025, -$4.8 million in Q2 2025, and -$5.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.65 Mn |
| Jun 30, 2025 | -4.83 Mn |
| Dec 31, 2024 | -5.72 Mn |
| Sep 30, 2024 | -6.99 Mn |
| Jun 30, 2024 | -5.24 Mn |
| Dec 31, 2023 | -2.82 Mn |
| Sep 30, 2023 | 7.33 Mn |
| Jun 30, 2023 | -5.62 Mn |
| Mar 31, 2023 | -4.76 Mn |
| Dec 31, 2022 | -29.98 Mn |
| Sep 30, 2022 | -3.17 Mn |
| Jun 30, 2022 | 3.91 Mn |
| Mar 31, 2022 | -5.39 Mn |
| Dec 31, 2021 | -35.59 Mn |
| Sep 30, 2021 | 3.80 Mn |
| Jun 30, 2021 | 5.93 Mn |
| Mar 31, 2021 | -5.12 Mn |
| Dec 31, 2020 | 27.36 Mn |
| Sep 30, 2020 | -5.12 Mn |
| Jun 30, 2020 | -5.03 Mn |